Reaction Details
Report a problem with these data
Report a problem with these dataTarget
Protein mono-ADP-ribosyltransferase PARP3
Ligand
BDBM50446130
Substrate
n/a
Meas. Tech.
ChEMBL_2238145 (CHEMBL5152041)
Kd
267±n/a nM
Citation
Johannes, JW; Balazs, A; Barratt, D; Bista, M; Chuba, MD; Cosulich, S; Critchlow, SE; Degorce, SL; Di Fruscia, P; Edmondson, SD; Embrey, K; Fawell, S; Ghosh, A; Gill, SJ; Gunnarsson, A; Hande, SM; Heightman, TD; Hemsley, P; Illuzzi, G; Lane, J; Larner, C; Leo, E; Liu, L; Madin, A; Martin, S; McWilliams, L; O'Connor, MJ; Orme, JP; Pachl, F; Packer, MJ; Pei, X; Pike, A; Schimpl, M; She, H; Staniszewska, AD; Talbot, V; Underwood, E; Varnes, JG; Xue, L; Yao, T; Zhang, K; Zhang, AX; Zheng, X Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}- J Med Chem 64:14498-14512 (2021) [PubMed] More Info.:
Target
Name:
Protein mono-ADP-ribosyltransferase PARP3
Synonyms:
ADP-ribosyltransferase diphtheria toxin-like 3 | ADPRT-3 | ADPRT3 | ADPRTL3 | ARTD3 | IRT1 | NAD(+) ADP-ribosyltransferase 3 | PARP-3 | PARP3 | PARP3_HUMAN | Poly [ADP-ribose] polymerase 3 | Poly[ADP-ribose] synthase 3 | hPARP-3 | pADPRT-3
Type:
PROTEIN
Mol. Mass.:
60091.40
Organism:
Homo sapiens (Human)
Description:
ChEMBL_109545
Residue:
533
Sequence:
MAPKPKPWVQTEGPEKKKGRQAGREEDPFRSTAEALKAIPAEKRIIRVDPTCPLSSNPGTQVYEDYNCTLNQTNIENNNNKFYIIQLLQDSNRFFTCWNRWGRVGEVGQSKINHFTRLEDAKKDFEKKFREKTKNNWAERDHFVSHPGKYTLIEVQAEDEAQEAVVKVDRGPVRTVTKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVHL
Inhibitor
Name:
BDBM50446130
Synonyms:
AG-014699 | AG-14447 | RUCAPARIB CAMSYLATE | Rucaparib
Type:
Small organic molecule
Emp. Form.:
C19H18FN3O
Mol. Mass.:
323.3641
SMILES:
CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23
Structure:
